ADAP
Adaptimmune Therapeutics
ADAP
ADAP
49 hedge funds and large institutions have $103M invested in Adaptimmune Therapeutics in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
49
Holding in Top 10
–
Calls
$29K
Puts
–
Top Buyers
| 1 | +$576K | |
| 2 | +$371K | |
| 3 | +$318K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$146K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$120K |
Top Sellers
| 1 | -$694K | |
| 2 | -$611K | |
| 3 | -$409K | |
| 4 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$355K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$228K |